Immunophenotyping of PBMCs derived from whole blood of 12 drug naïve (newly diagnosed) PD patients, 84 PD patients receiving treatment, and 62 healthy control subjects, showed that PD patients exhibited increased CD14+ monocytes, indicative of a pro-inflammatory state. This evidence concerns the gene CD14 and Parkinson disease.